US3966924A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition and method for treating psoriasis
Assignee: Allergan Inc
•
Filing: 1974-11-13
•
Granted: 1976-06-29
•
Expires: 1994-11-13
Abstract
Abstract A composition and method for treating psoriasis in humans comprising the topical administration to a human suffering from psoriasis of an effective dose for treating psoriasis of a composition comprising from about 0.01 to about 5% of a corticosteroid and preferably a halogenated corticosteroid and from about 0.05 to about 10% of 5-fluorouracil together with a suitable topical carrier.
Inventors
- 👤 Torsten Fredriksson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 10:57
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
50 words
A method for treating psoriasis in humans comprising the topical administration to a human suffering from psoriasis of an effective dose for treating psoriasis of a composition comprising as active ingredients, from about 0.025 to about 0.1% by weight of β-methasone valerate and about 1 to about 5% of 5-fluorouracil.
Claim 2
Independent Claim
50 words
A method for treating psoriasis in humans comprising the topical administration to a human suffering from psoriasis of an effective dose for treating psoriasis of a composition comprising as active ingredients, from about 0.025 to about 0.1% by weight of β-methasone valerate and about 1 to about 5% of 5-fluorouracil.
Claim 3
Independent Claim
50 words
A method for treating psoriasis in humans comprising the topical administration to a human suffering from psoriasis of an effective dose for treating psoriasis of a composition comprising as active ingredients, from about 0.025 to about 0.1% by weight of fluocinolone acetonide and about 1 to about 5% of 5-fluorouracil.
Claim 4
Independent Claim
50 words
A method for treating psoriasis in humans comprising the topical administration to a human suffering from psoriasis of an effective dose for treating psoriasis of a composition comprising as active ingredients, from about 0.025 to about 0.1% by weight of fluocinolone acetonide and about 1 to about 5% of 5-fluorouracil.
Claim 5
Dependent Claim
30 words
A composition for treating psoriasis in humans comprising as active ingredients, from about 0.025 to about 0.1% by weight of β-methasone valerate and about 1 to about 5% of 5-fluorouracil.
Claim 6
Dependent Claim
30 words
A composition for treating psoriasis in humans comprising as active ingredients, from about 0.025 to about 0.1% by weight of β-methasone valerate and about 1 to about 5% of 5-fluorouracil.
Claim 7
Dependent Claim
30 words
A composition for treating psoriasis in humans comprising as active ingredients, from about 0.025 to about 0.1% by weight of fluocinolone acetonide and about 1 to about 5% of 5-fluorouracil.
Claim 8
Dependent Claim
30 words
A composition for treating psoriasis in humans comprising as active ingredients, from about 0.025 to about 0.1% by weight of fluocinolone acetonide and about 1 to about 5% of 5-fluorouracil.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-06-29 | 1979-12-29 | 1980-06-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-06-29 | 1983-12-29 | 1984-06-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-06-29 | 1987-12-29 | 1988-06-29 | $7700.00 | Window Closed / Lapsed |